Reimbursement Briefs: OIG News; Next-Gen Sequencing Guidance
This article was originally published in The Gray Sheet
HHS Office of Inspector General finds Medicare pays more than double what private insurers pay for vacuum erection systems , and recommends CMS review its error-rate reduction plans for claims administration contractors. Baltimore-based group to develop guidance to evaluate next-gen sequencing-based tests for cancer. More reimbursement news.
You may also be interested in...
Medicare Durable Equipment Cuts Will Deepen In Next Round Of Competitive Bidding
Starting July 1, Medicare plans to pay 45 percent less than current fee-schedule rates for eight categories of DMEPOS in 91 cities, and 72 percent less nationwide for diabetes products.
Huma Secures EU MDR Approval For Medtech Software That Can Be Used In Any Disease
Huma Therapeutics has secured the first ever EU regulatory approval for a “disease agnostic” class IIb medtech software platform. CEO Dan Vahdat tells Medtech Insight how the product can be configured to monitor patients with any condition.
Moderna CEO Hearing Highlights Dissatisfaction With Patient Assistance Programs
There was bipartisan agreement that Moderna need to ensure that its patient assistance program will be easily accessible for under- and uninsured patients once the US switches to a commercial market for COVID vaccines – a sign of broader frustration with industry copay support initiatives.